What it's for (Indications)
- Dextrose IV solution is primarily indicated for providing a source of calories and fluid for patients who cannot obtain adequate nourishment orally or who require parenteral fluid support.
- It is commonly used in the management of hypoglycemia, providing a readily available energy substrate to correct low blood glucose levels.
- Furthermore, dextrose solutions serve as a vehicle and diluent for the intravenous administration of various compatible medications, ensuring their safe and effective delivery into the systemic circulation.
- In specific clinical scenarios, hypertonic dextrose solutions, often in conjunction with insulin, are utilized in the acute management of hyperkalemia to shift potassium intracellularly.
- It is also employed for hydration purposes in conditions requiring parenteral fluid and electrolyte replacement, contributing to overall fluid balance and preventing dehydration.
- The specific concentration of dextrose used depends on the patient's metabolic needs, fluid status, and the therapeutic goal, ranging from isotonic solutions for basic hydration to hypertonic solutions for significant caloric support or hypoglycemia correction.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of Dextrose IV solution is highly individualized and must be determined by a qualified healthcare professional based on the patient's age, weight, clinical condition, metabolic requirements, and the specific indication for use. Factors such as fluid balance, electrolyte status, and blood glucose levels must be meticulously monitored throughout the infusion. Typical concentrations range from 5% (D5W) for hydration and medication dilution, to 10% (D10W), 20% (D20W), or even 50% (D50W) for significant caloric support or acute hypoglycemia. The rate of infusion should be adjusted to prevent hyperglycemia, osmotic diuresis, or fluid overload. Pediatric patients, especially neonates and infants, require careful titration due to their limited metabolic capacity and increased susceptibility to fluid and electrolyte imbalances. Blood glucose monitoring is essential to avoid both hyperglycemia and rebound hypoglycemia, particularly when high concentrations or rapid infusions are utilized. Electrolyte supplements may also be required based on ongoing laboratory assessments. |
Safety & Warnings
Common Side Effects
- Administration of Dextrose IV solution can lead to several potential side effects, primarily related to fluid, electrolyte, and glucose imbalances.
- Common adverse reactions include hyperglycemia, especially in patients with diabetes mellitus, stress-induced hyperglycemia, or those receiving high infusion rates.
- Conversely, abrupt cessation of high-rate dextrose infusions can precipitate rebound hypoglycemia.
- Fluid overload, potentially manifesting as peripheral or pulmonary edema, can occur, particularly in patients with compromised cardiac or renal function.
- Electrolyte disturbances, notably dilutional hyponatremia, are a significant concern, especially in pediatric patients or those predisposed to fluid retention or inappropriate antidiuretic hormone secretion.
- Other potential side effects include hypokalemia, hypomagnesemia, and hypophosphatemia.
- Local reactions at the infusion site, such as pain, phlebitis, venous irritation, or thrombophlebitis, can occur, particularly with hypertonic solutions or prolonged infusions.
- Rarely, allergic reactions have been reported.
Serious Warnings
- Black Box Warning: Dextrose IV solutions do not carry a formal FDA-mandated Black Box Warning. However, healthcare professionals must be acutely aware of several serious warnings that require meticulous attention and management to ensure patient safety, particularly concerning fluid and electrolyte balance and metabolic control. **Serious Warnings: Risk of Severe Hyponatremia and Fluid Overload** Intravenous administration of dextrose solutions, especially hypotonic formulations after glucose metabolism (e.g., D5W), can cause severe, potentially fatal hyponatremia. This risk is significantly elevated in pediatric patients, elderly individuals, and patients with underlying conditions that predispose to fluid retention, impaired water excretion, or increased secretion of antidiuretic hormone (ADH), such as post-operative state, trauma, sepsis, heart failure, renal insufficiency, or those receiving medications that increase ADH effects. Severe symptomatic hyponatremia can lead to acute cerebral edema, seizures, permanent neurological damage, and death. Close monitoring of serum sodium, fluid balance, and neurological status is critical. Furthermore, rapid or excessive administration of dextrose solutions can lead to fluid overload, resulting in peripheral or pulmonary edema, and potentially exacerbating or precipitating congestive heart failure, particularly in patients with compromised cardiovascular or renal function. Careful assessment of fluid status, cardiac function, and renal function is imperative prior to and during therapy. Metabolic complications, including hyperglycemia, electrolyte disturbances (e.g., hypokalemia, hypophosphatemia), and rebound hypoglycemia upon abrupt discontinuation, also necessitate vigilant monitoring and appropriate intervention.
- Careful monitoring is paramount during the administration of Dextrose IV solution to prevent potentially severe adverse outcomes.
- Patients with diabetes mellitus or impaired glucose tolerance require vigilant blood glucose monitoring to avoid hyperglycemia, which can lead to osmotic diuresis and dehydration.
- Conversely, abrupt discontinuation of high-rate dextrose infusions can cause rebound hypoglycemia.
- Patients at risk for fluid overload, such as those with cardiac or renal insufficiency, liver disease, or pre-existing edema, must be closely monitored for signs of fluid retention, including pulmonary edema and congestive heart failure.
- A critical warning relates to the risk of dilutional hyponatremia, particularly in pediatric patients, elderly individuals, and those with conditions predisposing to increased antidiuretic hormone (ADH) secretion (e.
- g.
- , pain, stress, surgery, trauma, sepsis).
- Severe, symptomatic hyponatremia can lead to acute cerebral edema, seizures, permanent neurological damage, and death.
- Infusion of hypotonic fluids, like D5W after metabolism, should be carefully considered in such populations.
- Use with caution in patients with known corn allergy, as dextrose is typically derived from corn.
- Ensure proper aseptic technique during preparation and administration to prevent infections.
- Always verify compatibility when used as a vehicle for other medications.
How it Works (Mechanism of Action)
Dextrose (D-glucose) is a monosaccharide and the primary physiological substrate for energy metabolism in the human body. When administered intravenously, it provides a readily available source of carbohydrates and calories, which are essential for cellular metabolic processes. Dextrose is metabolized through glycolysis to pyruvate, which then enters the Krebs cycle to produce adenosine triphosphate (ATP), the main energy currency of cells. This metabolic process yields carbon dioxide and water as end products. In solution, dextrose contributes to the osmotic pressure of the extracellular fluid; hypertonic dextrose solutions (e.g., D10W, D50W) exert a significant osmotic effect, transiently drawing fluid from the intracellular to the extracellular compartment. After metabolism, the water component of dextrose solutions contributes to total body water. Dextrose also plays a crucial role in maintaining blood glucose homeostasis, preventing hypoglycemia, and supporting protein-sparing effects by providing an alternative energy source, thereby reducing the catabolism of endogenous proteins for gluconeogenesis.
Commercial Brands (Alternatives)
No other brands found for this formula.